Fidelity Investments
ZEAL

Fidelity Investments’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

Fidelity Investments’s Portfolio ZEAL Stock Details ZEAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-25,496
Closed -$347K – 2753
2017
Q4 		$347K Sell
25,496
-128,350
-83% -$2.02M ﹤0.01% 2568
2017
Q3 		$2.95M Buy
+153,846
New +$2.9M ﹤0.01% 2261

Other funds holding ZEAL

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $1.24B AUM 2.91% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Fidelity Investments's ZEAL Position: Q1 2018 in Review

Fidelity Investments sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q1 2018, closing a stake of 25,496 shares — an estimated $347K sold.

Fidelity Investments first reported a position in ZEAL in Q3 2017 and held it in 2 quarters. The position peaked at $2.95M in Q3 2017. 11 funds tracked by Wall St. Rank hold ZEAL as of Q1 2018.

  • Fidelity Investments reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q1 2018 after selling out during the quarter.
  • Fidelity Investments sold 25,496 Zealand Pharma A/S American Depositary Shares shares in Q1 2018, an estimated $347K.
  • Fidelity Investments first reported a position in Zealand Pharma A/S American Depositary Shares in Q3 2017 and held it in 2 quarters.
  • Fidelity Investments's Zealand Pharma A/S American Depositary Shares position peaked at $2.95M in Q3 2017.
  • 11 funds tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q1 2018.

Based on Fidelity Investments's 13F filing for Q1 2018, filed 14 May 2018.